IceCure Medical Ltd
ICCM · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.58 | 0.10 | -0.10 | -0.35 |
| FCF Yield | -22.58% | -26.62% | -26.46% | -15.09% |
| EV / EBITDA | -3.18 | -2.55 | -2.08 | -6.50 |
| Quality | ||||
| ROIC | -204.96% | -122.05% | -64.33% | -34.14% |
| Gross Margin | 44.09% | 40.26% | 46.84% | 53.04% |
| Cash Conversion Ratio | 0.82 | 0.85 | 0.84 | 1.27 |
| Growth | ||||
| Revenue 3-Year CAGR | 2.18% | -7.94% | -8.93% | 35.65% |
| Free Cash Flow Growth | 2.82% | 14.37% | -15.57% | -232.12% |
| Safety | ||||
| Net Debt / EBITDA | 0.46 | 0.65 | 1.40 | 2.57 |
| Interest Coverage | 0.00 | 0.00 | -70.04 | -56.87 |
| Efficiency | ||||
| Inventory Turnover | 0.93 | 0.85 | 0.57 | 0.99 |
| Cash Conversion Cycle | 174.48 | 347.13 | 520.25 | 269.76 |